CW July 2006

category image Volume 15
Issue Number 7
July 2006
ISSN 10593802

Switch to Letrozole Improves Breast Cancer Survival After Taking Tamoxifen

Post-menopausal women with breast cancer who switch from tamoxifen (Nolvadex) to letrozole (Femara) show dramatic reduction in risk of recurrence, distant metastasis, and better survival.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Presented at the American Society of Clinical Oncology Annual Meeting in Atlanta.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW July 2006

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login